3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial - The Lancet
Effects of liraglutide on visceral and ectopic fat in adults with overweight and obesity at high cardiovascular risk: a randomised, double-blind, placebo-controlled, clinical trial - The Lancet Diabetes & Endocrinology
Study design of Liraglutide Effect and Action in Diabetes 6 (LEAD 6). | Download Scientific Diagram
Addition of liraglutide vs addition of a single dose of insulin aspart to insulin degludec plus metformin in patients with type 2 diabetes - Media Centre | EASD
Comparison of Low-Dose Liraglutide Use Versus Other GLP-1 Receptor Agonists in Patients Without Type 2 Diabetes
Clinical Considerations When Initiating and Titrating Insulin Degludec/ Liraglutide (IDegLira) in People with Type 2 Diabetes | SpringerLink
Liraglutide in Adults with Type 2 Diabetes: Global Perspective on Safety, Efficacy and Patient Preference - Daisuke Yabe, Yutaka Seino, 2011
Liraglutide Vs Exenatide | Differences Between Saxenda & Byetta | myBMI
Cureus | Weight Loss Effects of Glucagon-Like Peptide-One Receptor Analog Treatment in a Severely Obese Patient During Hospital Admission | Article
Liraglutide (Saxenda) for Weight Loss | AAFP
What is the Maximum/Lowest Dosing of Victoza?
Tips for Pharmacists | Saxenda® (liraglutide) Injection 3 mg
How Victoza® Works | Victoza® (liraglutide) injection 1.2 mg or 1.8 mg